MARKET

GTH

GTH

Genetron Holdings Ltd
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.95
-0.08
-0.40%
After Hours: 19.80 -0.15 -0.75% 16:33 04/16 EDT
OPEN
20.08
PREV CLOSE
20.03
HIGH
20.19
LOW
18.71
VOLUME
182.24K
TURNOVER
--
52 WEEK HIGH
31.54
52 WEEK LOW
9.03
MARKET CAP
1.76B
P/E (TTM)
-1.2730
1D
5D
1M
3M
1Y
5Y
Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021
Business Wire · 5d ago
Genetron Health to Present at the SVB Leerink CybeRx Series: Liquid Biopsy & Oncology Dx Summit
BEIJING, April 01, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening p...
GlobeNewswire · 04/01 22:00
Genetron Health Presented Its Proprietary Early Screening Technology Mutation Capsule at Science/AAAS Webinar
Business Wire · 04/01 11:39
Genetron Holdings Limited (NASDAQ:GTH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$26.22
Shareholders in Genetron Holdings Limited ( NASDAQ:GTH ) had a terrible week, as shares crashed 21% to US$18.25 in the...
Simply Wall St. · 03/27 08:10
The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 24)
Benzinga · 03/25 11:58
Genetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue Guidance
Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development...
Business Wire · 03/25 11:47
Genetron Holdings Ltd - ADR to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 25, 2021 / Genetron Holdings Ltd - ADR (NASDAQ:GTH) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 8:30 AM Eastern Time.To listen to the event live or a...
ACCESSWIRE · 03/25 11:30
Genetron Holdings EPS beats by $0.05, beats on revenue; outlook
Genetron Holdings (GTH): Q4 Non-GAAP EPS of -$0.02 beats by $0.05; GAAP EPS of -$0.02 beats by $0.04.Revenue of $20.5M beats by $0.36M.FY2021: Revenue to be around RMB615M-RMB625M, representing around
Seekingalpha · 03/25 10:57
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GTH. Analyze the recent business situations of Genetron Holdings Ltd through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average GTH stock price target is 25.52 with a high estimate of 30.00 and a low estimate of 21.09.
EPS
Institutional Holdings
Institutions: 60
Institutional Holdings: 17.95M
% Owned: 20.31%
Shares Outstanding: 88.36M
TypeInstitutionsShares
Increased
13
2.08M
New
16
215.72K
Decreased
9
720.22K
Sold Out
6
920.75K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About GTH
Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.

Webull offers kinds of Genetron Holdings Ltd - ADR stock information, including NASDAQ:GTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GTH stock methods without spending real money on the virtual paper trading platform.